STOCK TITAN

Starling Oncology (STLN) Stock Price, News & Analysis

STLN NASDAQ

Company Description

Starling Oncology (NASDAQ: STLN) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $502.9M.

This page collects what Stock Titan holds for STLN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$6.12
+21.67%
+1.09
Last updated: August 6, 2026 at 19:59
-
Performance 1 year
$502.9M

Starling Oncology (STLN) stock last closed at $4.99. At a market capitalization of $502.9M, STLN is classified as a small-cap stock with approximately 100.0M shares outstanding.

See what a $1,000 investment in STLN would be worth today

Latest News

Starling Oncology has 1 recent news article, with the latest published yesterday. Key topics include earnings. View all STLN news →

SEC Filings

No SEC filings available for STLN.

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

STLN Company Profile & Sector Positioning

Starling Oncology (STLN) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Starling Oncology (STLN)?

The current stock price of Starling Oncology (STLN) is $4.99 as of August 6, 2026.

What is the market cap of Starling Oncology (STLN)?

The market cap of Starling Oncology (STLN) is approximately 502.9M. Learn more about what market capitalization means .